Georgia Keresty's most recent trade in Solid Biosciences Inc was a trade of 77,500 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 13,300 | 13,300 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 9,200 | 41,083 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 77,500 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,450 | 11,450 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 8,000 | 31,883 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,515 | 11,515 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 7,737 | 23,883 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 34,400 | 34,400 | - | - | Director Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 16,146 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 11,721 (0%) | 0% | 0 | Common Stock | |
| Solid Biosciences Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 51,000 | 51,000 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 3,465 | 0 (0%) | 0% | - | Common Stock | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 1,684 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 1,531 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 1,444 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 May 2022 | 303 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 826 | 3,465 (0%) | 0% | 0 | Common Stock | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,531 | 1,531 | - | - | Director Stock Option (Right to Buy) | |
| Aspen Technology Inc | Georgia Keresty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 866 | 2,639 (0%) | 0% | 0 | Common Stock |